A Trial of the Implantable Artificial Bronchus 50 Flex in Patients With Severe Emphysema

Sponsor
Pulmair Medical, Inc.
Study ID
NCT07086339
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
22 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Implantable pulmonary stent — DEVICE
    Implantable polymer based pulmonary stent for severe COPD/emphysema

Study Details

A Study at Two Hospitals Testing the Safety and Effectiveness of the IAB 50 Flex, a New Implant for Adults with Severe COPD or Emphysema

Key Dates

First listed
Jul 25, 2025
Start date
Feb 4, 2026
Status verified
Jun 2026
Primary completion
Aug 31, 2027
Completion
Dec 31, 2027

Study Design

Enrollment
20 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Treatment group
    One or two procedures involving placement of up to 10 IAB implants in one or both lungs

Primary Outcome Measure

Incidence of serious adverse events [ Time Frame: Ninety (90) days from the last IAB implanted. ]

Central Contacts

Find similar trials

Nationwide
COPD trialsPulmonology trialsLung disease trials

Related Studies